A gene with the cryptic abbreviation CRELD1, which plays a role in the development of the heart in the foetus, also appears to fulfil a key function in the human immune system. If the gene is not sufficiently active, this leads to characteristic changes in the immune response, causing it to lose its effectiveness. Medical experts refer to this as ‘ageing of the immune system’, as a similar effect is often observed in older people. In the medium term, the findings could potentially help to mitigate these age-related declines.
Whilst analysing transcription data from a total of 4,500 participants, the researchers came across a surprising correlation: among the participants analysed were some in whom the CRELD1 gene was, for whatever reason, significantly less active. Interestingly, the blood of these participants contained very few so-called T-cells. These play an important role in fighting off infections.
In experiments on mice, the researchers investigated this link further and demonstrated that mice lacking the gene died earlier. This phenomenon, also known as immunosenescence, is also observed in older people. Those affected are significantly more susceptible to infections, but possibly also to age-related diseases such as cancer or Alzheimer’s. At the same time, there are centenarians who, from an immunological perspective, are several decades younger.
The long-term aim is now to maintain the activity of this gene. This might significantly reduce the risk of disease in older people.
References: University of Bonn, Radboud University Nijmegen, University of Liège, Hannover Medical School, Helmholtz Centre Braunschweig
. CRELD1 modulates homeostasis of the immune system in mice and humans. *Nature Immunology*, 9 November 2020; https://www.nature.com/articles/s41590-020-00811-2